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Early detection and treatment of left ventricular
dysfunction is of major importance. Ideally, therapy
will be performed before irreversible cardiac damage
has occurred. To do this, a sensitive evaluation of
cardiac function and cardiac mechanics is required.
However, cardiac function is difﬁcult to deﬁne and
the assessment of function in a clinical context often
uses a surrogate for function. One can divide cardiac
function in intrinsic myocyte function or contractility
and ventricular pump function [1]. Force develop-
ment results in the generation of sufﬁcient pressure to
open the cardiac valves. On the other hand results
deformation of the ventricles in the ejection of blood.
The interaction between force development and
deformation are determined by ventricular wall
properties such as tissue composition, ﬁbre structure
and global geometry on one hand and the interaction
between the heart and the loading conditions on the
other hand. The most reliable parameter to measure
intrinsic myocardial contractility is by calculation
of the end-systolic pressure-volume relationship
(E-max) [2]. This is an invasive technique and not
always applicable in clinical practice. Therefore in
clinical practice, surrogate measurements of force
development and volume ejection are used with non-
invasive techniques, like echocardiography, magnetic
resonance imaging or computed tomography. The
evaluation of ejection fraction with these techniques,
however has severe shortcomings because the assess-
ment of intrinsic cardiac function using ejection
fraction depends on geometric assumptions. Volume
based indices are load dependent and these param-
eters only assess global function. To overcome these
problems, new echocardiographic techniques, like
tissue Doppler imaging have been developed, which
measure myocardial motion and deformation.
Tissue Doppler imaging uses the shifts of ultra-
sound waves to calculate myocardial velocity. It can
be done with the pulsed Doppler technique and the
color-coded tissue Doppler technique. Measurement
of the ratio of transmitral peak inﬂow velocity of
early rapid diastolic ﬁlling (E), and measurement of
Ea, obtained by pulsed-TDE sample volume placed in
the lateral annulus imaged from the four chamber
view can be used as an indicator of left ventricular
ﬁlling pressures [3].
Brain natriuretic peptide is a natriuretic hormone,
that is present in the heart, particularly in the
ventricles. Brain natriuretic peptide has diuretic,
natriuretic and hypotensive effects. It inhibits the
rennin-angiotensin system, endothelin secretion and
sympathetic activity [4]. The release of BNP is
increased in heart failure, as ventricular cells secrete
BNP in response to high ventricular ﬁlling pressures
[5]. In normal subjects, the plasma concentrations
of BNP and NT-proBNP are similar. However, in
L. H. B. Baur (&)
Department of Cardiology, Atrium Medical Centre
Parkstad, Henri Dunantstreet 5, 6401CX Heerlen,
The Netherlands
e-mail: lbr01@atriummc.nl
123
Int J Cardiovasc Imaging (2008) 24:409–410
DOI 10.1007/s10554-008-9294-4patients with left ventricular dysfunction, plasma NT-
proBNP rises more than BNP [6]. It can be used to
diagnose but more to rule out heart failure. BNP can
be used as a bedside test to rule out heart failure at the
ﬁrst aid department in patients with dyspnea [7].
Although the sensitivity, speciﬁcity and predictive
value are high in patients with sinusrythm, BNP loses
its sensitivity and speciﬁcity in patients with atrial
ﬁbrillation [8]. False positive NT pro-BNP results can
be diminished by adding the age of and clinical
characteristics of the individual for stratiﬁcation of
patients with dyspnea [9, 10].
The current study of Mornos et al. [11] showed a
close correlation of NT-proBNP with a combination
of conventional Doppler echocardiography of the E
velocity of transmitral ﬂow and two TDI parameters:
Ea and Sa. The last parameters explore both diastolic
and systolic left ventricular performance.
The study shows,that after initial screening ofheart
failure patients with BNP or NT-proBNP additional
echocardiographic imaging with TDI can give the
information about ventricular geometry, morphology
and the presence of systolic or diastolic function. The
study also shows, that tissue Doppler imaging has to
become a standard tool for the evaluation of heart
failurepatients.Wehavetokeepinmindhowever,that
measurement of plasma BNP or NT-proBNP can help
in discrimination of dyspnea of cardiac or non-cardiac
causes, but gives no information about the etiology of
cardiac dyspnea. Cardiac imaging with echo, Doppler
echo, tissue Doppler echo, Stress Echo, Magnetic
Resonance Imaging, Stress MRI, Nuclear (Stress
Imaging) and Conventional Coronary angiography or
CT coronary angiography is still needed to explore the
underlying cardiac pathology.
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